Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Line of Sight

PET and MRI imaging techniques are beginning to enter onto the radar of the pharma industry. Kevin Cox from Imanova is sure they will become key tools in early-stage drug development decision-making, but warns that preconceptions that imaging is costly must be tackled first.

Kevin Cox, Imanova (March 2014)

Keywords: Imaging biomarkers, Positron emission tomography, Magnetic resonance imaging, Fast-to-fail strategies, Multimodal approach

    View full article    |    Back to Discovery Technology section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |